194 related articles for article (PubMed ID: 12212776)
1. Brain-imaging surrogate markers for detection and prevention of age-related memory loss.
Small GW
J Mol Neurosci; 2002; 19(1-2):17-21. PubMed ID: 12212776
[TBL] [Abstract][Full Text] [Related]
2. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
Small GW
Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
[TBL] [Abstract][Full Text] [Related]
3. Imaging, subjective complaints, and MCI: 30 years before.
Galluzzi S; Frisoni GB
J Nutr Health Aging; 2008 Jan; 12(1):80S-3S. PubMed ID: 18165851
[TBL] [Abstract][Full Text] [Related]
4. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
[TBL] [Abstract][Full Text] [Related]
5. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease.
Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H
Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519
[TBL] [Abstract][Full Text] [Related]
6. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
7. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
[TBL] [Abstract][Full Text] [Related]
8. Patterns of brain activation in people at risk for Alzheimer's disease.
Bookheimer SY; Strojwas MH; Cohen MS; Saunders AM; Pericak-Vance MA; Mazziotta JC; Small GW
N Engl J Med; 2000 Aug; 343(7):450-6. PubMed ID: 10944562
[TBL] [Abstract][Full Text] [Related]
9. Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.
Rapoport SI
Proc Natl Acad Sci U S A; 2000 May; 97(11):5696-8. PubMed ID: 10811924
[No Abstract] [Full Text] [Related]
10. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
11. Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.
Small GW; Chen ST; Komo S; Ercoli L; Bookheimer S; Miller K; Lavretsky H; Saxena S; Kaplan A; Dorsey D; Scott WK; Saunders AM; Haines JL; Roses AD; Pericak-Vance MA
Am J Psychiatry; 1999 Jul; 156(7):1035-8. PubMed ID: 10401448
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers, ketone bodies, and the prevention of Alzheimer's disease.
VanItallie TB
Metabolism; 2015 Mar; 64(3 Suppl 1):S51-7. PubMed ID: 25468143
[TBL] [Abstract][Full Text] [Related]
13. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
[TBL] [Abstract][Full Text] [Related]
15. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
16. Memory function in a mouse genetic model of Alzheimer's disease.
Avdesh A; Wong P; Martins RN; Martin-Iverson MT
J Alzheimers Dis; 2011; 25(3):433-44. PubMed ID: 21460433
[TBL] [Abstract][Full Text] [Related]
17. Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.
Rabinovici GD; Roberson ED
Ann Neurol; 2010 Mar; 67(3):283-5. PubMed ID: 20373338
[No Abstract] [Full Text] [Related]
18. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
[TBL] [Abstract][Full Text] [Related]
19. Diminished neuronal metabolic activity in Alzheimer's disease. Review article.
Salehi A; Swaab DF
J Neural Transm (Vienna); 1999; 106(9-10):955-86. PubMed ID: 10599878
[TBL] [Abstract][Full Text] [Related]
20. [The role of cholesterol in Alzheimer's neuro-pathogenesis].
Biondi E
Riv Biol; 2006; 99(2):210-5. PubMed ID: 17115369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
